Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 64.29B | 65.16B | 64.78B | 65.83B | 66.58B | 59.08B |
Gross Profit | 16.93B | 17.68B | 15.72B | 17.46B | 19.27B | 18.06B |
EBITDA | 4.19B | 6.85B | 1.55B | 4.21B | 5.64B | 5.38B |
Net Income | -22.00M | 1.78B | -2.31B | 365.00M | 1.31B | 1.17B |
Balance Sheet | ||||||
Total Assets | 102.58B | 102.11B | 101.75B | 97.02B | 95.06B | 91.14B |
Cash, Cash Equivalents and Short-Term Investments | 4.86B | 5.44B | 5.16B | 4.55B | 5.48B | 8.38B |
Total Debt | 40.67B | 39.93B | 39.72B | 36.60B | 33.64B | 35.62B |
Total Liabilities | 57.24B | 56.49B | 57.04B | 52.62B | 50.88B | 50.02B |
Stockholders Equity | 44.46B | 44.71B | 43.86B | 43.35B | 43.15B | 40.23B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -440.00M | -933.00M | -3.34B | 940.00M | -960.00M |
Operating Cash Flow | 0.00 | 3.98B | 4.03B | 109.00M | 4.60B | 4.09B |
Investing Cash Flow | 0.00 | -3.63B | -5.07B | -2.94B | -3.92B | -5.27B |
Financing Cash Flow | 0.00 | 71.00M | 1.53B | 1.94B | -3.80B | 2.83B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | ¥25.93B | 14.75 | 5.12% | 1.57% | 20.22% | ||
72 Outperform | ¥5.87B | 58.04 | 2.47% | 4.82% | -89.35% | ||
65 Neutral | ¥8.13B | 7.86 | 5.18% | 8.65% | 84.32% | ||
65 Neutral | ¥7.64B | 4.29 | 2.93% | 0.58% | ― | ||
64 Neutral | £1.70B | 10.48 | 6.12% | 260.21% | 0.58% | -32.48% | |
55 Neutral | ¥7.70B | 117.73 | 5.75% | 2.17% | -101.54% | ||
52 Neutral | ¥9.94B | 3.86 | 4.44% | -0.65% | -100.90% |